Details for Patent: 9,279,794

Which drugs does patent 9,279,794 protect, and when does it expire?

Patent 9,279,794 protects INOMAX and is included in one NDA.

Protection for INOMAX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-five patent family members in nine countries.

Summary for Patent: 9,279,794

Title:	Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide
Abstract:	Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
Inventor(s):	Tolmie; Craig R. (Stoughton, WI), Milsap; Jeff (Cambridge, WI), Acker; Jaron M. (Madison, WI)
Assignee:	Mallinckrodt Hospital Products IP Limited (Dublin, IE)
Application Number:	14/626,409
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,279,794
Patent Claim Types: see list of patent claims	Use; Delivery; Device;

Drugs Protected by US Patent 9,279,794

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mallinckrodt Hosp	INOMAX	nitric oxide	GAS;INHALATION	020845-003	Dec 23, 1999	AA	RX	Yes	Yes					Y

International Family Members for US Patent 9,279,794

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015218945
Australia	2019253886
Brazil	112016018076